Total: 3 |
|
PMID (PMCID) | ||
---|---|---|
27258362 |
FEMALE | |
Atelosteogenesis type III: orthopedic management. | ||
Sarikaya IA, Gorgun B, Erdal OA. J Pediatr Orthop B. 2017;26(6):546-551. |
||
Atelosteogenesis type III is a rare autosomal dominant skeletal dysplasia caused by mutations in the synthesis of the protein filamin B (FLNB). | ||
10076882 |
MIXED_SAMPLE | Adult |
Atelosteogenesis type III: long term survival, prenatal diagnosis, and evidence for dominant transmission. | ||
Schultz C, Langer LO, Laxova R, Pauli RM. Am J Med Genet. 1999;83(1):28-42. |
||
The clinical and radiologic phenotype of atelosteogenesis, type III overlaps with that of another skeletal dysplasia, autosomal dominant Larsen syndrome; these most likely represent allelic conditions. | ||
2368807 |
MIXED_SAMPLE | Infant, Newborn |
Atelosteogenesis type III: a distinct skeletal dysplasia with features overlapping atelosteogenesis and oto-palato-digital syndrome type II. | ||
Stern HJ, Graham JM Jr, Lachman RS, Horton W, Bernini PM, Spiegel PK, Bodurtha J, Ives EJ, Bocian M, Rimoin DL. Am J Med Genet. 1990;36(2):183-95. |
||
Atelosteogenesis type III: a distinct skeletal dysplasia with features overlapping atelosteogenesis and oto-palato-digital syndrome type II. |